- CitiesIncreases training capacity and number of faculty and clinically trained professionals in palliative and hospice care a…
- Potential benefitTargets resources to rural, frontier, medically underserved, tribal, pediatric, and racial/ethnic minority populations…
- Federal agenciesProvides federal funding for faculty career awards, retraining fellowships, and short intensive courses that may create…
Palliative Care and Hospice Education and Training Act
Referred to the House Committee on Energy and Commerce.
This bill (Palliative Care and Hospice Education and Training Act) amends the Public Health Service Act to authorize federal grant and contract programs to expand education, training, faculty development, fellowships, and research in palliative care and hospice across medical, nursing, social work, physician assistant, chaplaincy, pharmacy, psychology, and other health professional programs. It creates Palliative Care and Hospice Education Programs with priority for rural, underserved, pediatric, and minority populations; establishes academic career awards, career incentive awards with service obligations, and short-term fellowships for faculty; authorizes NIH to develop a palliative care research strategy; and directs federal dissemination of palliative care information.
Adequacy of funding and scale: liberals see funding as a useful start (but potentially too small), conservatives worry about recurring federal spending.
Relative to its intended legislative type, this bill is a substantive statutory package that creates and integrates multiple grant and award programs, authorizes specified funding levels, and assigns responsibilities to HHS/NIH with generally clear program definitions and eligibility rules.
This bill (Palliative Care and Hospice Education and Training Act) amends the Public Health Service Act to authorize federal grant and contract programs to expand education, training, faculty development, fellowships, and research in palliative care and hospice across medical, nursing, social work, physician assistant, chaplaincy, pharmacy, psychology, and other health professional programs.
It creates Palliative Care and Hospice Education Programs with priority for rural, underserved, pediatric, and minority populations; establishes academic career awards, career incentive awards with service obligations, and short-term fellowships for faculty; authorizes NIH to develop a palliative care research strategy; and directs federal dissemination of palliative care information.
The bill authorizes appropriations of $15 million per year for 2026–2030 for the main education programs and $5 million per year for 2026–2030 for nursing-focused programs, caps some awards (e.g., up to $150,000 per award and up to 24 programs for certain fellowships), and includes clarifications that funds may not be used for services ineligible for federal funding or to assist in causing death.
On content alone the bill is targeted, technocratic, and low‑cost, addressing workforce gaps and research needs—areas that often attract bipartisan support. Its built‑in limits, priorities for underserved populations, and explicit noncontroversial clarifications further reduce political friction. The main obstacles are procedural (committee action, floor scheduling, and separate appropriations action to actually fund the authorized programs) rather than substantive opposition.
Relative to its intended legislative type, this bill is a substantive statutory package that creates and integrates multiple grant and award programs, authorizes specified funding levels, and assigns responsibilities to HHS/NIH with generally clear program definitions and eligibility rules. It provides concrete elements (award amounts, caps, priorities, service requirements) while leaving implementation details and many performance targets to agency administration.
Adequacy of funding and scale: liberals see funding as a useful start (but potentially too small), conservatives worry about recurring federal spending.
Who stands to gain, and who may push back.
These are examples from the analysis, not a ranked list of the most-affected groups.
- Federal agenciesAdds federal spending (authorized totals of roughly $20 million per year 2026–2030) and administrative costs; critics m…
- Potential burdenRequires institutions to apply, comply with maintenance-of-effort assurances, and track service obligations and trainin…
- Local governmentsSome may contend the programs could duplicate existing federal or private palliative/geriatric education efforts or cro…
Why the argument around this bill splits.
Adequacy of funding and scale: liberals see funding as a useful start (but potentially too small), conservatives worry about recurring federal spending.
A mainstream liberal would likely view this bill positively as a targeted federal investment to strengthen the palliative and hospice workforce, improve care for seriously ill patients, and address disparities in rural, pediatric, and minority communities.
They would see the bill’s emphasis on interprofessional education, faculty career support, and NIH research expansion as consistent with priorities to improve quality of life and equity in serious-illness care.
They would note the explicit prohibition against funding assisted suicide as a helpful clarification while welcoming the outreach and patient information provisions.
A centrist/moderate would likely view the bill as a pragmatic, narrowly focused federal effort to address gaps in palliative and hospice training and research.
They would appreciate the bill’s specificity (career awards, fellowships, caps on awards, prioritization criteria) and its safeguards (nonduplication, maintenance-of-effort, prohibition on funding assisted suicide).
At the same time a centrist would want clear performance measures, oversight, and cost accountability and would be attentive to how the authorized funds translate into measurable increases in workforce capacity.
A mainstream conservative would acknowledge the value of improving care for seriously ill patients and may welcome measures that support family-centered hospice services, but would be cautious about creating new federal grant programs and recurring discretionary spending.
They are likely to raise concerns about federal overreach into health-professions education, the expansion of NIH research priorities, and the absence of offsets for the authorized appropriations.
The statutory clarifications that federal funds cannot support assisted suicide or ineligible services will be viewed positively.
The path through Congress.
Reached or meaningfully advanced
Reached or meaningfully advanced
Still ahead
Still ahead
Still ahead
On content alone the bill is targeted, technocratic, and low‑cost, addressing workforce gaps and research needs—areas that often attract bipartisan support. Its built‑in limits, priorities for underserved populations, and explicit noncontroversial clarifications further reduce political friction. The main obstacles are procedural (committee action, floor scheduling, and separate appropriations action to actually fund the authorized programs) rather than substantive opposition.
- Whether appropriators will provide the authorized funding in future appropriations bills; authorization does not guarantee appropriation.
- Committee priorities and calendar: the bill requires committee markup and favorable reporting before floor consideration, which is uncertain and can be affected by competing legislative priorities.
Recent votes on the bill.
No vote history yet
The bill has not accumulated any surfaced votes yet.
Go deeper than the headline read.
Adequacy of funding and scale: liberals see funding as a useful start (but potentially too small), conservatives worry about recurring fede…
On content alone the bill is targeted, technocratic, and low‑cost, addressing workforce gaps and research needs—areas that often attract bi…
Relative to its intended legislative type, this bill is a substantive statutory package that creates and integrates multiple grant and award programs, authorizes specified funding levels, and assigns responsibilities to…
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.